Cypherpunk Technologies Inc. Common Stock (CYPH)
Stock · NASDAQ · Health Care
$2.57as of 10/16/2026
Price chart
Active signals
CYPH Signal Track Record
How signals performed across all stocks →What CYPH's price did in the 20 trading sessions after each past signal, compared with any 20-session window over the same period.
| Signal | Times | Median 20-session return | Higher after 20 sessions | Last signal |
|---|---|---|---|---|
| Volume Spike | 40 | -8.4% | 48% | September 16, 2026 |
| Bollinger Band Breakout | 25 | -6.7% | 48% | September 17, 2026 |
| Bollinger Band Breakdown | 19 | -17.6% | 47% | June 5, 2026 |
| 200-Day Moving Average TouchActive now | 12 | -18.8% | 33% | February 19, 2026 |
| Any 20-session window (baseline) | -4.2% | 45% |
Computed by MarketWall from daily closing prices since May 18, 2022. Returns are close-to-close and don't include dividends. Past results describe what happened before; they are not a forecast and not investment advice.
About CYPH
Cypherpunk Technologies Inc., a privacy technology company, implements a digital asset strategy anchored by Zcash in the United States. The company is involved in identifying, developing, investing in, acquiring, and building privacy-enhancing technologies; and accumulating digital assets, such as ZCash. It also develops biomarker-targeted antibody therapies for patients with cancer and other diseases comprising DKN-…
- Sector
- Health Care
- Industry
- Biotechnology: Pharmaceutical Preparations
- Employees
- 6
- Website
- www.leaptx.com/
Fundamentals
- 1-day range
- $3.01$3.42
- Market cap
- $71.74M
- P/E (trailing)
- —
- P/E (forward)
- -33.67
- EPS (trailing)
- $-0.10
- Dividend yield
- —
- Beta
- 1.13
- Avg. volume
- 9.46M
Forecasts
1 analyst ratings
Cypherpunk Technologies Inc. Common Stock Competitors
Chosen by industry and closest market cap.
- CYPHCypherpunk Technologies Inc. Common Stock$2.57▼ 14.90%Market cap $71.74MP/E —$0.393$4.19
- ELTXElicio Therapeutics Inc. Common Stock$1.56▼ 12.36%Market cap $72.28MP/E —$1.71$16
- ACRVAcrivon Therapeutics Inc. Common Stock$1.64▼ 6.82%Market cap $72.33MP/E —$1.27$3.56
- CTORCitius Oncology Inc. Common Stock$0.768▲ 2.95%Market cap $70.67MP/E —$0.491$2.25
- SPROSpero Therapeutics Inc. Common Stock$1.1▼ 2.65%Market cap $73.53MP/E 8.91$1.08$3.08
- INOInovio Pharmaceuticals Inc. Common Stock$0.99▼ 4.81%Market cap $69.62MP/E —$0.5632$2.72
- XBITXBiotech Inc. Common Stock$2.12▼ 1.85%Market cap $69.51MP/E —$2.09$3.44
| Symbol | Market cap | P/E ratio | Price | 1D | 52-week range |
|---|---|---|---|---|---|
| CYPH Cypherpunk Technologies Inc. Common Stock | $71.74M | — | $2.57 | ▼ 14.90% | $0.393$4.19 |
| ELTX Elicio Therapeutics Inc. Common Stock | $72.28M | — | $1.56 | ▼ 12.36% | $1.71$16 |
| ACRV Acrivon Therapeutics Inc. Common Stock | $72.33M | — | $1.64 | ▼ 6.82% | $1.27$3.56 |
| CTOR Citius Oncology Inc. Common Stock | $70.67M | — | $0.768 | ▲ 2.95% | $0.491$2.25 |
| SPRO Spero Therapeutics Inc. Common Stock | $73.53M | 8.91 | $1.1 | ▼ 2.65% | $1.08$3.08 |
| INO Inovio Pharmaceuticals Inc. Common Stock | $69.62M | — | $0.99 | ▼ 4.81% | $0.5632$2.72 |
| XBIT XBiotech Inc. Common Stock | $69.51M | — | $2.12 | ▼ 1.85% | $2.09$3.44 |
P/E shows — for peers not currently carrying a live signal of their own.
Latest news
- Applied Digital, Bitdeer Technologies, ON Semiconductor And Other Big Stocks Moving Higher On FridayBenzinga · 10/2/2026
- Crypto Exchange Gemini Switches Zcash SoftwareYahoo · 9/30/2026
- Hewlett Packard Enterprise, Capital Bancorp, FormFactor And Other Big Stocks Moving Higher On WednesdayBenzinga · 9/30/2026
- MRNA On Track To Be September's No. 2 S&P 500 Stock — But These 5 Smaller Health Care Names Did Even BetterYahoo · 9/25/2026
- 10 Health Care Stocks Whale Activity In Today’s SessionBenzinga · 9/24/2026
- 12 Health Care Stocks Moving In Thursday's Intraday SessionBenzinga · 9/17/2026
- Gapping stocks in Wednesday's sessionChartMill · 9/16/2026
- 12 Health Care Stocks Moving In Wednesday's Pre-Market SessionBenzinga · 9/16/2026
Insider Activity
Insider Actions →- Khing Djien Oei · September 25, 2026 · Sale168.8K @ $3.92
- Patricia A. Martin · September 23, 2026 · Sale50.0K @ $3.86
- Thomas John Dietz · August 26, 2026 · Sale20.0K @ $1.72
- Zhang Kevin · August 21, 2026 · Grant2.00M
- McEvoy William Patrick III · August 17, 2026 · J43.29M @ $0.77
- McEvoy William Patrick III · August 17, 2026 · X16.57M @ $0.001
- Winklevoss Capital Fund, LLC · August 17, 2026 · J43.29M @ $0.77
- Winklevoss Capital Fund, LLC · August 17, 2026 · X16.57M @ $0.001
- Patricia A. Martin · July 1, 2026 · Grant75.0K
- McEvoy William Patrick III · July 1, 2026 · Grant1.00M
- Nissim Mashiach · July 1, 2026 · Grant75.0K
- William Li · July 1, 2026 · Grant75.0K
- Douglas E. Onsi · July 1, 2026 · Grant1.00M
- Christian M. Richard · July 1, 2026 · Grant75.0K
- Khing Djien Oei · July 1, 2026 · Grant100.0K
Institutional Ownership
March 31, 2026
- Total shares held
- 8.35M
- Total value held
- $6.58M
- Institutional holders
- 40
- Unknown2.34M
- Unknown1.82M
- Unknown1.22M
- Unknown725.1K
- Unknown571.1K
- Unknown252.1K
- Unknown171.1K
- Unknown162.5K
- Unknown140.1K
- Unknown118.0K
See the full, filterable feed with live charts on the MarketWall dashboard.
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
September 29, 2026
CYPH in Spotlight as Smaller Health Care Names Outperform
Recent coverage noted that smaller health‑care names outperformed larger peers, and CYPH is among those that could benefit from the sector’s momentum. The same report highlighted significant whale activity in health‑care stocks, suggesting growing institutional interest. These developments may affect CYPH’s trading dynamics. No specific price guidance is provided.
CYPH in Spotlight as Smaller Health Care Names Outperform. Recent coverage noted that smaller health‑care names outperformed larger peers, and CYPH is among those that could benefit from the sector’s momentum. The same report highlighted significant whale activity in health‑care stocks, suggesting growing institutional interest. These developments may affect CYPH’s trading dynamics. No specific price guidance is provided.